Home » Topics » Regulatory » Patents

Patents
RSS

Pharmacia & Upjohn describes agents for 5-HT1A receptor-mediated disorders

April 17, 1997

SKB describes 5-HT2C/5-HT2B antagonists

April 17, 1997

Novel bisphosphonates revealed by Yissum

April 17, 1997

Esters of estrogenic compounds from Lilly

April 16, 1997

Meiji Seika discloses new cardiotonic agents

April 16, 1997

5-HT2 antagonists/5-HT reuptake inhibitors described by Yamanouchi

April 16, 1997

Pola discloses antitumor/immunosuppressive agents

April 16, 1997

Antitumor indane derivatives from Taiho

April 16, 1997

Nippon Kayaku isolates novel antitumor agents

April 16, 1997

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...